BP505T Unit-II Pharmaceutical Jurisprudence: Drugs & Cosmetics Act, 1940 | B.Pharm Notes

B.PHARM 5TH SEMESTER • BP505T • UNIT-II

Drugs and Cosmetics Act, 1940 & Rules, 1945

Schedules • Sale • Labelling • Packing • Regulatory Authorities

Unit-II of BP505T Pharmaceutical Jurisprudence deals with important schedules under the Drugs Rules, 1945, provisions relating to sale of drugs, labelling and packing requirements, permitted colours and the administration of the Drugs and Cosmetics Act and Rules. The unit is especially important for understanding how drugs are classified and controlled at the level of manufacture, distribution and sale.

1. Unit-II Syllabus at a Glance

Drug Schedules

Schedules G, H, M, N, P, T, U, V, X, Y, Part XII-B, Schedule F and DMR (OA).

Sale of Drugs

Wholesale, retail sale and restricted licences.

Labelling & Packing

General labelling requirements, specimen labels and permitted colours.

Administration

DTAB, CDL, DCC, Government Analysts, Licensing Authorities, Controlling Authorities and Drugs Inspectors.

2. Drug Schedules under the Drugs Rules, 1945

The schedules attached to the Drugs Rules provide detailed requirements for particular classes of drugs, manufacturing conditions, standards, labelling, storage, sale and other regulatory matters.

Important: Schedules are periodically amended through notifications. Therefore, for legal accuracy, students should distinguish the traditional B.Pharm examination description from the current regulatory position. CDSCO provides the current Drugs Rules and amendment notifications on its official website. :contentReference[oaicite:1]{index=1}

3. Schedule G

SCHEDULE G

Schedule G is associated with drugs that are required to carry the prescribed cautionary statement indicating that they should be used under medical supervision.

Exam concept: Schedule G → Medical supervision / cautionary labelling

Schedule G Drug → Cautionary Statement → Medical Supervision → Safe Use

4. Schedule H

SCHEDULE H

Schedule H contains prescription drugs subject to the applicable requirements for sale and labelling. The label carries the prescribed warning regarding sale on the prescription of a Registered Medical Practitioner.

Remember:
Schedule H → Prescription drug → Prescribed warning on label

Schedule H → Prescription → Registered Medical Practitioner → Controlled Sale

5. Schedule M

SCHEDULE M

Schedule M specifies requirements relating to Good Manufacturing Practices (GMP) and requirements of premises, plant and equipment for pharmaceutical manufacturing.

Premises

Requirements relating to pharmaceutical manufacturing premises.

Plant

Requirements for appropriate manufacturing plant and facilities.

Equipment

Requirements for suitable manufacturing equipment.

GMP

Controls intended to maintain consistent product quality.

Schedule M → Premises + Plant + Equipment + GMP → Quality Manufacture

6. Schedule N

SCHEDULE N

Schedule N specifies the minimum requirements of equipment and facilities required for running a pharmacy.

Exam shortcut:
Schedule M → Manufacturing premises, plant, equipment & GMP
Schedule N → Pharmacy premises, equipment & facilities

7. Schedule P

SCHEDULE P

Schedule P deals with the prescribed life period of drugs and requirements relating to storage conditions for specified drugs.

Schedule P → Specified Drugs → Life Period + Storage Conditions

8. Schedule T

SCHEDULE T

Schedule T contains requirements relating to Good Manufacturing Practices for Ayurvedic, Siddha and Unani medicines under the applicable regulatory framework.

Remember:
Schedule T → GMP for ASU medicines

9. Schedule U

SCHEDULE U

Schedule U is associated with requirements concerning manufacturing and analytical records for drugs, including information to be maintained during manufacture and testing.

Manufacture → Records → Testing / Analysis → Documentation

10. Schedule V

SCHEDULE V

Schedule V specifies standards relating to certain patent or proprietary medicines and includes prescribed requirements such as standards and limits applicable to specified preparations.

Exam focus: Remember Schedule V in association with standards for specified patent or proprietary medicines.

11. Schedule X

SCHEDULE X

Schedule X contains specified drugs subject to particularly stringent controls relating to their sale, prescription, record-keeping and storage under the applicable Rules.

Schedule X → Prescription Control → Record Keeping → Secure Storage → Strict Regulatory Control

12. Schedule Y

SCHEDULE Y

Schedule Y was historically associated with requirements and guidelines for clinical trials and approval of certain new drugs under the Drugs Rules.

Important regulatory update: Students should not treat older descriptions of Schedule Y as a complete statement of the current new-drug and clinical-trial framework. New drugs and clinical trials are now principally addressed under the New Drugs and Clinical Trials Rules, 2019 and subsequent amendments.

New Drug → Regulatory Data → Clinical / Scientific Evaluation → Regulatory Decision

13. Part XII-B

PART XII-B

Part XII-B contains provisions dealing with specified requirements under the Drugs Rules. For examination purposes, students should study the specific provisions and subject matter prescribed in the latest syllabus/reference text.

Study tip: Because the Rules have undergone amendments, use the latest CDSCO version when preparing exact statutory details.

14. Schedule F

SCHEDULE F

Schedule F contains requirements relating to standards and requirements applicable to specified biological and other specialized products and associated testing or regulatory controls, as applicable to the particular part of the Schedule.

15. DMR (OA)

DMR (OA)

DMR (OA) refers to provisions dealing with specified drugs and medical requirements under the applicable regulatory framework. Students should study the exact provisions specified in the prescribed B.Pharm reference material and current Rules.

16. Important Schedules – Quick Revision Table

Schedule	Major examination association
G	Drugs requiring prescribed cautionary statement / medical supervision.
H	Prescription drugs and prescribed warning/labelling requirements.
M	GMP and requirements of premises, plant and equipment for manufacture.
N	Minimum requirements for premises, equipment and facilities of a pharmacy.
P	Life period and storage requirements for specified drugs.
T	GMP requirements for Ayurvedic, Siddha and Unani medicines.
U	Manufacturing and analytical records.
V	Standards for specified patent or proprietary medicines.
X	Specified drugs under stringent prescription, sale, storage and record controls.
Y	Historically associated with new-drug/clinical-trial requirements; current framework includes NDCT Rules, 2019.

17. Sale of Drugs

The Drugs Rules regulate the sale of drugs through different categories of licences and conditions. The requirements vary according to the nature of the sale and the category of drug.

Drug Sale → Wholesale or Retail or Restricted Sale

18. Wholesale Sale

Wholesale sale involves supply of drugs to eligible purchasers and is subject to the applicable licence, premises, storage and qualified-person requirements.

Licence

Appropriate wholesale drug licence as prescribed.

Premises

Suitable premises and storage facilities.

Qualified Personnel

Required competent/qualified person according to the applicable licence category.

Records

Purchase and sale records as required by the Rules.

19. Retail Sale

Retail sale refers to supply of drugs directly to consumers or patients through an authorized retail establishment in accordance with the applicable licence and legal requirements.

Licensed Retailer → Valid Prescription where Required → Dispensing / Sale → Patient / Consumer

20. Restricted Licence

A restricted licence applies to specified situations where drugs may be sold subject to prescribed restrictions and conditions. The exact scope depends upon the applicable provisions of the Rules.

Exam point: Restricted licence does not mean unrestricted retail sale. The activity remains subject to the limitations and conditions prescribed by the Rules.

21. Wholesale vs Retail vs Restricted Sale

Feature	Wholesale	Retail	Restricted
Primary activity	Supply to eligible purchasers.	Sale/dispensing to consumers or patients.	Sale subject to prescribed restrictions.
Licence	Wholesale licence.	Retail licence.	Restricted licence.
Storage	Applicable storage requirements.	Applicable storage requirements.	Applicable requirements.
Records	Required records must be maintained.	Required records must be maintained.	Records as applicable.

22. Labelling of Drugs

Labelling provides essential information about a drug and enables identification, safe use, traceability and regulatory compliance. The Drugs Rules prescribe the manner in which required information is to appear on drug labels.

The Rules specifically provide that drugs should not be sold or distributed unless labelled in accordance with the applicable requirements. :contentReference[oaicite:2]{index=2}

Drug → Correct Label → Identification → Safe Use → Legal Compliance

23. General Labelling Requirements

Important Information on a Drug Label

• Name of the drug.
• Proper name and applicable trade name requirements.
• Net contents / quantity, where applicable.
• Active ingredients and relevant strength.
• Batch or lot identification.
• Manufacturing licence details, where applicable.
• Date of manufacture, where required.
• Expiry date / date requirements applicable under the Rules.
• Manufacturer's name and address.
• Required statutory warnings and cautionary statements.
• Storage conditions where applicable.

Important: The exact particulars vary according to the category of drug and the applicable Rule/Schedule. The current Rules should be consulted for the legally prescribed wording and placement.

24. Specimen Drug Label – Educational Diagram

PHARMADIGILIB PHARMA

Product: Example Drug Tablets

Strength: 500 mg

Batch No.: ABC123

Mfg. Date: MM/YYYY

Expiry: MM/YYYY

Storage: As directed / prescribed

Manufactured by: Example Pharmaceuticals

Manufacturing Licence No.: XXXXX

STATUTORY WARNING / CAUTIONARY STATEMENT

Educational specimen only. It is not a legally compliant commercial label.

25. Packing of Drugs

Packaging protects the drug from contamination, deterioration, physical damage and other factors that may compromise quality. Packaging and labelling requirements depend on the product and the applicable legal provisions.

Drug Product → Container → Closure → Label → Outer Pack → Safe Distribution

26. Permitted Colours in Drugs and Cosmetics

The Drugs Rules regulate the use of colouring substances in drugs and cosmetics. Only permitted colours and conditions applicable to the relevant product category should be used.

Remember: Colouring agents are not selected merely for appearance. Their use is subject to regulatory requirements concerning permitted colours, purity and applicable product categories.

27. Administration of the Drugs and Cosmetics Act and Rules

Administration involves several statutory and regulatory bodies, authorities and officers responsible for technical advice, laboratory testing, inspection, licensing and enforcement.

Drugs & Cosmetics Act & Rules ↓ Central / State Regulatory System ↓ Technical Advice ↓ Laboratory Testing ↓ Licensing ↓ Inspection & Enforcement

28. Drugs Technical Advisory Board (DTAB)

The Drugs Technical Advisory Board (DTAB) is a statutory technical advisory body associated with the administration of the Drugs and Cosmetics Act.

Nature

Technical advisory body.

Function

Provides technical advice on matters arising from administration of the Act and Rules.

Importance

Supports evidence-based technical decision-making in drug regulation.

29. Central Drugs Laboratory (CDL)

The Central Drugs Laboratory performs statutory testing and analytical functions under the Drugs and Cosmetics regulatory framework.

Drug Sample → Laboratory Testing → Analysis → Analytical Report

30. Drugs Consultative Committee (DCC)

The Drugs Consultative Committee is associated with promoting uniformity in the administration of the Drugs and Cosmetics Act and Rules across the country.

Exam shortcut:
DTAB → Technical advice
DCC → Uniform administration / coordination

31. Government Analysts

Government Analysts are appointed for the purposes of analysis of drug and cosmetic samples according to the provisions of the legislation.

Official Sample → Government Analyst → Testing / Analysis → Analytical Report

32. Licensing Authorities

Licensing Authorities are responsible for granting and administering licences according to the applicable provisions of the Drugs Rules.

Licence Grant

Process applications for applicable licences.

Conditions

Apply prescribed licence conditions.

Compliance

Monitor regulatory compliance as provided by law.

Regulatory Action

Take appropriate action where statutory requirements are not satisfied.

33. Controlling Authorities

Controlling authorities exercise regulatory oversight over licensing and enforcement functions according to the applicable provisions. They support supervision of the licensing system and regulatory implementation.

34. Drugs Inspectors

Drugs Inspectors are regulatory officers responsible for inspection, sampling and enforcement activities under the Drugs and Cosmetics Act and Rules, within their assigned jurisdiction and statutory powers.

Drug Inspector → Inspection → Sampling → Investigation → Regulatory Action

35. Regulatory Authorities – Quick Comparison

Authority / Officer	Main examination association
DTAB	Technical advice on matters arising under the Act and Rules.
DCC	Promotes uniformity in administration of the Act and Rules.
Central Drugs Laboratory	Statutory laboratory testing and analytical functions.
Government Analyst	Analysis of official drug/cosmetic samples.
Licensing Authority	Grant and administration of applicable licences.
Controlling Authority	Supervision and regulatory oversight.
Drugs Inspector	Inspection, sampling and enforcement functions.

36. Administration – Master Flowchart

Drugs & Cosmetics Regulatory System → DTAB + DCC + CDL
↓
Licensing Authorities → Controlling Authorities → Drugs Inspectors → Regulatory Enforcement

37. Complete Unit-II Regulatory Flow

Drug → Applicable Schedule → Manufacture → Labelling & Packing → Licence → Wholesale / Retail → Inspection → Regulatory Compliance

38. Offences and Penalties

Failure to comply with the requirements of the Drugs and Cosmetics Act and Rules can result in regulatory and legal action. The exact offence and penalty depend on the provision violated and the applicable law in force.

Examination tip: Do not memorize penalties from outdated notes without checking the current statutory provisions. The penalty framework has been amended over time.

39. Quick Revision Table

Topic	Remember
Schedule G	Medical supervision / cautionary requirement.
Schedule H	Prescription drugs.
Schedule M	GMP, premises, plant and equipment.
Schedule N	Pharmacy premises and equipment.
Schedule P	Life period and storage requirements.
Schedule T	GMP for ASU medicines.
Schedule U	Manufacturing and analytical records.
Schedule V	Standards for specified patent/proprietary medicines.
Schedule X	Stringent controls for specified drugs.
Schedule Y	Historical new-drug/clinical-trial framework; current framework also involves NDCT Rules, 2019.
DTAB	Technical advice.
DCC	Uniformity in administration.
CDL	Laboratory testing.
Government Analyst	Analysis of official samples.
Drugs Inspector	Inspection, sampling and enforcement.

40. Important Examination Questions

Long Answer Questions

1. Discuss the important provisions of Schedules G, H, M, N, P, T, U, V, X and Y.
2. Explain the requirements for wholesale, retail and restricted sale of drugs.
3. Discuss the general labelling and packing requirements of drugs.
4. Explain the administration of the Drugs and Cosmetics Act and Rules.
5. Describe the constitution and functions of DTAB and DCC.
6. Explain the role and functions of Government Analysts and Drugs Inspectors.

Short Answer Questions

1. Write a note on Schedule G.
2. Write a note on Schedule H.
3. What is Schedule M?
4. Write the importance of Schedule N.
5. What is Schedule P?
6. Write a note on Schedule T.
7. What is Schedule X?
8. Write a note on Schedule Y.
9. What is a restricted licence?
10. Differentiate wholesale and retail sale.
11. Write general requirements of drug labelling.
12. Write a note on permitted colours.
13. What is DTAB?
14. What is DCC?
15. Write the functions of a Government Analyst.
16. Write the functions of a Drugs Inspector.

41. Interactive Quick Quiz

Q1. Which Schedule is associated with GMP and requirements of premises, plant and equipment for pharmaceutical manufacture?

Q2. Schedule H is primarily associated with:

Q3. Which body provides technical advice under the Drugs and Cosmetics regulatory framework?

Q4. Government Analysts are primarily associated with:

Q5. Which activity is a major function of Drugs Inspectors?

42. Unit-II Memory Map

Schedules
G → Medical supervision
H → Prescription
M → GMP / Manufacturing
N → Pharmacy
P → Life period / Storage
T → ASU GMP
U → Records
V → Standards
X → Strict control
Y → Historical new-drug/clinical-trial framework

Sale
Wholesale → Retail → Restricted

Administration
DTAB → Technical advice
DCC → Uniform administration
CDL → Laboratory
Government Analyst → Analysis
Licensing Authority → Licensing
Drugs Inspector → Inspection & Enforcement

Academic & Legal Note: These notes are prepared for B.Pharm educational and examination purposes. Pharmaceutical legislation is dynamic. CDSCO publishes updated versions of the Drugs Rules and subsequent amendment notifications. Therefore, exact statutory wording, schedules, labelling requirements, licence conditions and penalties should be verified against the latest official provisions before using these notes for regulatory practice. :contentReference[oaicite:3]{index=3}

43. Official Regulatory Reference

For the latest Drugs Rules, 1945 and amendments, students can refer to the official Central Drugs Standard Control Organization (CDSCO) website.

View Drugs Rules – CDSCO

PharmaDigiLib.in
B.Pharm 5th Semester • BP505T Pharmaceutical Jurisprudence
Unit-II • Drugs and Cosmetics Act, 1940 & Rules, 1945